Literature DB >> 7217675

Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes.

J Bray, R U Lemieux, T A McPherson.   

Abstract

Using an artificial T hapten, we have confirmed that human sera contain agglutinins for neuraminidase-treated red blood cells (N'RBC), specific for the disaccharide beta DGal(1 leads to 3)alpha DGalNAc. Further, we have shown that these agglutinins are antibodies largely of the IgM subclass that bind equally to neuraminidase-treated lymphocytes (N'lymphocytes). The anti-T antibody in human serum is cytotoxic for N'RBC in complement fixation assays. The synthetic hapten has biologic activity as shown in inhibition experiments and by the specificity of a rabbit antibody raised to the hapten for the naturally occurring antigen on N'RBC and N'lymphocytes. An immunoadsorbent prepared from the hapten was used to obtain biologically active antibodies from human serum with specificity for the naturally occurring antigen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7217675

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.

Authors:  G F Springer; S M Murthy; P R Desai; W A Fry; H Tegtmeyer; E F Scanlon
Journal:  Klin Wochenschr       Date:  1982-02-01

2.  A method for T-antigen demonstration by a polyclonal antibody and peanut lectin; elimination of cross-reaction with naturally occurring antibodies.

Authors:  T F Orntoft
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

3.  Sialidase activity and antibodies to sialidase-treated autologous erythrocytes in bronchoalveolar lavages from patients with idiopathic pulmonary fibrosis or sarcoidosis.

Authors:  C R Lambré; Y Pilatte; S Le Maho; A Greffard; H De Crémoux; J Bignon
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

4.  Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: a correlation with disease burden.

Authors:  J Bray; G D MacLean; F J Dusel; T A McPherson
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

5.  Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.

Authors:  E J Brown; K A Joiner; M M Frank
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

Review 6.  The glycans of stem cells.

Authors:  Pascal M Lanctot; Fred H Gage; Ajit P Varki
Journal:  Curr Opin Chem Biol       Date:  2007-07-27       Impact factor: 8.822

7.  A unique natural human IgG antibody with anti-alpha-galactosyl specificity.

Authors:  U Galili; E A Rachmilewitz; A Peleg; I Flechner
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

8.  Targeted glycoproteomic identification of cancer cell glycosylation.

Authors:  Alex S Powlesland; Paul G Hitchen; Simon Parry; Sarah A Graham; Maria Marcela Barrio; Maria Teresa Elola; José Mordoh; Anne Dell; Kurt Drickamer; Maureen E Taylor
Journal:  Glycobiology       Date:  2009-05-11       Impact factor: 4.313

9.  Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues.

Authors:  U Galili; B A Macher; J Buehler; S B Shohet
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.